Nanocurcumin preserves kidney function and haematology parameters in DMBA-induced ovarian cancer treated with cisplatin via its antioxidative and anti-inflammatory effect in rats

• Egile Nagusiak: Melva Louisa (Egilea), Erico Wanafri (Egilea), Wawaimuli Arozal (Egilea), Ni Made Dwi Sandhiutami (Egilea), Ahmad Muhammad Basalamah (Egilea)
• Formatua: Liburua
• Argitaratua: Taylor & Francis Group, 2023-12-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

AbstractContext Cisplatin, as a first-line treatment for ovarian cancer, is associated with debilitating adverse effects, including nephrotoxic and haematotoxic effects.Objective This study determines whether nanocurcumin, combined with cisplatin, would give additional benefit to kidney function and...